150 related articles for article (PubMed ID: 9075664)
1. Decreased endotoxin-binding capacity of whole blood in patients with alcoholic liver disease.
Schäfer C; Greiner B; Landig J; Feil E; Schütz ET; Bode JC; Bode C
J Hepatol; 1997 Mar; 26(3):567-73. PubMed ID: 9075664
[TBL] [Abstract][Full Text] [Related]
2. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay.
Fukui H; Brauner B; Bode JC; Bode C
J Hepatol; 1991 Mar; 12(2):162-9. PubMed ID: 2050995
[TBL] [Abstract][Full Text] [Related]
3. Concentrations of lipopolysaccharide-binding protein, bactericidal/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease.
Schäfer C; Parlesak A; Schütt C; Bode JC; Bode C
Alcohol Alcohol; 2002; 37(1):81-6. PubMed ID: 11825862
[TBL] [Abstract][Full Text] [Related]
4. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess.
Bode C; Kugler V; Bode JC
J Hepatol; 1987 Feb; 4(1):8-14. PubMed ID: 3571935
[TBL] [Abstract][Full Text] [Related]
5. Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease.
Urbaschek R; McCuskey RS; Rudi V; Becker KP; Stickel F; Urbaschek B; Seitz HK
Alcohol Clin Exp Res; 2001 Feb; 25(2):261-8. PubMed ID: 11236841
[TBL] [Abstract][Full Text] [Related]
6. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial.
Bode C; Schäfer C; Fukui H; Bode JC
Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106
[TBL] [Abstract][Full Text] [Related]
7. Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan.
Wong J; Zhang Y; Patidar A; Vilar E; Finkelman M; Farrington K
PLoS One; 2016; 11(10):e0164978. PubMed ID: 27764208
[TBL] [Abstract][Full Text] [Related]
8. Relation of endotoxin, endotoxin binding proteins and macrophages to severe alcoholic liver injury and multiple organ failure.
Fukui H
Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):172S-179S. PubMed ID: 16344605
[TBL] [Abstract][Full Text] [Related]
9. Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease.
Schäfer C; Schips I; Landig J; Bode JC; Bode C
Z Gastroenterol; 1995 Sep; 33(9):503-8. PubMed ID: 8525652
[TBL] [Abstract][Full Text] [Related]
10. A study of endotoxaemia in patients with primary biliary cirrhosis.
Yamamoto Y; Sezai S; Sakurabayashi S; Hirano M; Kamisaka K; Oka H
J Int Med Res; 1994; 22(2):95-9. PubMed ID: 8020644
[TBL] [Abstract][Full Text] [Related]
11. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
[TBL] [Abstract][Full Text] [Related]
12. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt.
Trebicka J; Krag A; Gansweid S; Appenrodt B; Schiedermaier P; Sauerbruch T; Spengler U
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1218-25. PubMed ID: 21971377
[TBL] [Abstract][Full Text] [Related]
13. Endotoxemia of cirrhosis: an observation not substantiated.
Fulenwider JT; Sibley C; Stein SF; Evatt B; Nordlinger BM; Ivey GL
Gastroenterology; 1980 May; 78(5 Pt 1):1001-4. PubMed ID: 6991352
[TBL] [Abstract][Full Text] [Related]
14. Endogenous endotoxemia in patients with liver cirrhosis--a quantitative analysis of endotoxin in portal and peripheral blood.
Tachiyama G; Sakon M; Kambayashi J; Iijima S; Tsujinaka T; Mori T
Jpn J Surg; 1988 Jul; 18(4):403-8. PubMed ID: 3172582
[TBL] [Abstract][Full Text] [Related]
15. Endotoxemia in alcoholic liver disease.
Fujita T
Hepatology; 2009 Oct; 50(4):1319; author reply 1319. PubMed ID: 19790084
[No Abstract] [Full Text] [Related]
16. Rifaximin improves thrombocytopenia in patients with alcoholic cirrhosis in association with reduction of endotoxaemia.
Kalambokis GN; Mouzaki A; Rodi M; Tsianos EV
Liver Int; 2012 Mar; 32(3):467-75. PubMed ID: 22098272
[TBL] [Abstract][Full Text] [Related]
17. Effect of ethanol challenge on serum glycoproteins in alcoholic and non-alcoholic liver disease.
Cobden I; Matthewson K; Carr WP; Dick WC; Record CO
Alcohol Alcohol; 1987; 22(3):257-63. PubMed ID: 2441717
[TBL] [Abstract][Full Text] [Related]
18. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation.
Lin RS; Lee FY; Lee SD; Tsai YT; Lin HC; Lu RH; Hsu WC; Huang CC; Wang SS; Lo KJ
J Hepatol; 1995 Feb; 22(2):165-72. PubMed ID: 7790704
[TBL] [Abstract][Full Text] [Related]
19. [Endotoxinemia in rats in the course of ethanol-induced liver damage].
Boron-Kaczmarska A; Kozlowska H; Swiderska J; Szmitkowski M; Szymanski J
Orv Hetil; 1994 Jul; 135(31):1705-8. PubMed ID: 8065750
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of plasma endotoxin levels in patients with cirrhosis.
Chan CC; Hwang SJ; Lee FY; Wang SS; Chang FY; Li CP; Chu CJ; Lu RH; Lee SD
Scand J Gastroenterol; 1997 Sep; 32(9):942-6. PubMed ID: 9299675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
